Guido Kroemer Selected Research

Cystic Fibrosis (Mucoviscidosis)

12/2020	The Multifaceted Roles of MicroRNAs in Cystic Fibrosis.
11/2019	Squaramide-based synthetic chloride transporters activate TFEB but block autophagic flux.
8/2019	Personalization of therapies in rare diseases: a translational approach for the treatment of cystic fibrosis.
7/2019	Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease.
3/2019	The gliadin-CFTR connection: new perspectives for the treatment of celiac disease.
1/2019	Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis.
1/2019	Therapeutic modulation of autophagy: which disease comes first?
1/2019	Defective proteostasis in celiac disease as a new therapeutic target.
9/2018	Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.
9/2018	Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guido Kroemer Research Topics

Disease

495	Neoplasms (Cancer) 04/2024 - 01/2002
36	Necrosis 01/2023 - 03/2004
35	Carcinogenesis 03/2024 - 11/2003
35	Breast Neoplasms (Breast Cancer) 02/2024 - 09/2007
32	Melanoma (Melanoma, Malignant) 02/2024 - 04/2006
27	Inflammation (Inflammations) 01/2024 - 10/2011
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2004
26	Obesity 01/2023 - 07/2010
26	Carcinoma (Carcinomatosis) 01/2023 - 01/2002
25	Infections 11/2023 - 03/2002
24	Starvation 11/2023 - 11/2005
19	Lung Neoplasms (Lung Cancer) 11/2023 - 03/2002
19	Tetraploidy 03/2023 - 06/2006
19	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2011
18	Cystic Fibrosis (Mucoviscidosis) 12/2020 - 09/2013
15	Hypoxia (Hypoxemia) 11/2022 - 07/2003
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 02/2008
12	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 05/2012
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 02/2006
10	COVID-19 02/2024 - 01/2020
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 12/2016
10	Ischemia 11/2022 - 07/2003
10	Polyploidy 11/2017 - 09/2004
9	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 09/2012
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2007
8	Colonic Neoplasms (Colon Cancer) 01/2022 - 04/2004
7	Dysbiosis 12/2023 - 01/2016
7	Mitochondrial Diseases (Mitochondrial Disease) 03/2022 - 01/2002
7	Residual Neoplasm 01/2021 - 10/2007
6	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 07/2012
6	Fibrosarcoma 11/2023 - 06/2013
6	Leukemia 10/2023 - 01/2005
6	Disease Progression 10/2023 - 05/2012
6	Lymphoma (Lymphomas) 10/2023 - 05/2016
6	Multiple Myeloma 01/2023 - 11/2013
6	Pancreatitis 01/2023 - 07/2009

Drug/Important Bio-Agent (IBA)

87	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2003
54	AntigensIBA 01/2024 - 09/2007
44	Antineoplastic Agents (Antineoplastics)IBA 11/2023 - 12/2007
39	AnthracyclinesIBA 01/2023 - 03/2007
34	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 05/2004
34	CalreticulinIBA 01/2022 - 01/2007
33	Adenosine Triphosphate (ATP)IBA 01/2022 - 04/2004
32	VaccinesIBA 01/2024 - 09/2003
31	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2016
30	Biomarkers (Surrogate Marker)IBA 02/2024 - 09/2007
29	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2006
26	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 09/2004
26	CytokinesIBA 01/2022 - 03/2002
21	Peptides (Polypeptides)IBA 01/2023 - 04/2006
21	HMGB1 Protein (HMG1)IBA 01/2022 - 09/2007
19	Monoclonal AntibodiesIBA 01/2024 - 01/2012
18	InterferonsIBA 01/2023 - 02/2006
17	Hormones (Hormone)IBA 02/2024 - 09/2006
17	LigandsIBA 12/2023 - 03/2002
17	Phosphotransferases (Kinase)IBA 01/2021 - 01/2008
16	5-methoxy-methylindoleacetic acid (DBI)IBA 01/2023 - 01/2019
15	CaspasesIBA 12/2018 - 01/2002
14	SpermidineIBA 01/2022 - 11/2009
13	AntibodiesIBA 01/2024 - 08/2011
13	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 08/2013
13	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 09/2007
11	CarcinogensIBA 01/2024 - 09/2012
11	LipidsIBA 01/2024 - 01/2008
11	Apoptosis Inducing FactorIBA 11/2022 - 06/2003
11	Therapeutic UsesIBA 01/2022 - 12/2007
9	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 04/2004
9	Messenger RNA (mRNA)IBA 01/2023 - 01/2017
9	Toll-Like Receptor AgonistsIBA 01/2023 - 08/2012
9	EnzymesIBA 01/2023 - 11/2011
9	Pattern Recognition ReceptorsIBA 01/2022 - 08/2009
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 03/2012
8	CopperIBA 03/2024 - 04/2011
8	Interferon Type IIBA 01/2024 - 11/2014
8	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023 - 01/2015
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 05/2004
8	PolyaminesIBA 11/2021 - 11/2009
8	InterleukinsIBA 01/2020 - 03/2010
8	InflammasomesIBA 01/2019 - 10/2009
8	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2019 - 03/2012
8	Toll-Like Receptor 4IBA 02/2016 - 09/2007
8	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2014 - 07/2007
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2007
7	Diazepam Binding InhibitorIBA 01/2023 - 10/2019
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 02/2007
7	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 07/2010
7	Transcription Factors (Transcription Factor)IBA 03/2022 - 03/2004
7	Histones (Histone)IBA 01/2021 - 06/2008
7	Sirolimus (Rapamycin)FDA Link 10/2019 - 01/2006
7	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 07/2019 - 12/2016
7	ErbB Receptors (EGF Receptor)IBA 12/2014 - 07/2007
6	IronIBA 04/2023 - 01/2018
6	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 01/2010
6	Phenobarbital (Luminal)FDA Link 01/2023 - 01/2017

Therapy/Procedure

183	Therapeutics 04/2024 - 01/2002
103	Drug Therapy (Chemotherapy) 03/2023 - 01/2002
87	Immunotherapy 02/2024 - 01/2008
31	Radiotherapy 01/2021 - 12/2006
9	Neoadjuvant Therapy 01/2021 - 09/2011
8	Caloric Restriction 03/2021 - 01/2010